Literature DB >> 19426794

Advantages of celecoxib nanosuspension formulation and transformation into tablets.

Andrej Dolenc1, Julijana Kristl, Sasa Baumgartner, Odon Planinsek.   

Abstract

Drugs with low aqueous solubility and high permeability (BCS class II) present a high proportion of all drugs. This study examines the critical issues regarding engineering of a nanosuspension tailored to increase drug dissolution rate and its transformation into dry powder suitable for tabletting. Nanosuspensions of celecoxib, a selective COX-2 inhibitor with low water solubility, were produced by the emulsion-diffusion method using three different stabilizers (Tween) 80, PVP K-30 and SDS) and characterized by particle size analysis, dissolution testing, scanning electron microscopy imaging, differential scanning calorimetry and X-ray powder diffraction. Spray-dried nanosuspension was blended with microcrystalline cellulose, and compressed to tablets, and their tensile strength, porosity and elastic recovery of tablets were investigated. The selection of solvent and stabilizers is critical, firstly to achieve controlled crystallization and size, and secondly to increase the wettability of the hydrophobic drug. The crystalline nano-sized celecoxib alone or in tablets showed a dramatic increase of dissolution rate and extent compared to micronized. SEM images showed that the nanoparticle morphology was influenced by the choice of stabilizers. Celecoxib nanosuspension stabilized with PVP K-30 and SDS showed advantages over Tween 80 due to sticking of the dried product and unexpected changes observed on DSC curves. Markedly lower compaction forces are needed for nano-sized compared to micro-sized celecoxib to produce tablets of equal tensile strength.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426794     DOI: 10.1016/j.ijpharm.2009.04.038

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  27 in total

1.  A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib.

Authors:  Yanzhuo Zhang; Hong Wang; Chuanjun Li; Baoxiang Sun; Yu Wang; Siling Wang; Cunqiang Gao
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

2.  Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2013-03-30       Impact factor: 3.246

3.  Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.

Authors:  Peng Liu; Odile De Wulf; Johanna Laru; Teemu Heikkilä; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Leena Peltonen; Timo Laaksonen
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

4.  Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.

Authors:  Peng Liu; Tapani Viitala; Alma Kartal-Hodzic; Huamin Liang; Timo Laaksonen; Jouni Hirvonen; Leena Peltonen
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

5.  Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.

Authors:  Anju Malkani; Abhijit A Date; Darshana Hegde
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

6.  Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug.

Authors:  Michael Morgen; Corey Bloom; Ron Beyerinck; Akintunde Bello; Wei Song; Karen Wilkinson; Rick Steenwyk; Sheri Shamblin
Journal:  Pharm Res       Date:  2011-08-24       Impact factor: 4.200

Review 7.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

8.  Transformation of Ritonavir Nanocrystal Suspensions into a Redispersible Drug Product via Vacuum Drum Drying.

Authors:  Barbara V Schönfeld; Ulrich Westedt; Benjamin-Luca Keller; Karl G Wagner
Journal:  AAPS PharmSciTech       Date:  2022-05-09       Impact factor: 3.246

Review 9.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

10.  Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Authors:  Bo Sun; Yoon Yeo
Journal:  Curr Opin Solid State Mater Sci       Date:  2012-12-01       Impact factor: 11.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.